Related Experiment Video
Updated: Jun 6, 2026
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
[RNA interference for cancer therapies].
1Department of Molecular Cell Physiology, Kyoto Prefectural University of Medicine and Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 19, 2010
Summary
Short interfering RNA (siRNA) offers a novel cancer therapy by silencing specific genes. Non-viral delivery systems enhance safety for clinical applications, showing promise in ongoing trials.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- RNA interference (RNAi) is a natural gene silencing process.
- Short interfering RNA (siRNA) leverages RNAi for therapeutic applications.
- siRNA-based cancer therapy is a developing field in nucleic acid medicine.
Purpose of the Study:
- To review the mechanism of RNAi and non-viral drug delivery systems (DDSs).
- To discuss the application of siRNA targeting polo-like kinase-1 (PLK-1) in cancer.
- To highlight current clinical trials for RNAi cancer therapies.
Main Methods:
- Review of RNA interference mechanisms.
- Discussion of non-viral drug delivery systems for siRNA.
- Analysis of siRNA targeting PLK-1 and current clinical trial data.
Main Results:
- siRNA demonstrates potential for sequence-specific gene silencing in cancer.
- Non-viral DDSs are favored for safer clinical translation of siRNA therapies.
- Targeted siRNA against PLK-1 shows promise in preclinical and clinical studies.
Conclusions:
- RNAi-based therapies, utilizing targeted siRNAs, represent a promising new avenue for cancer treatment.
- Effective delivery systems are crucial for the success of siRNA cancer therapies.
- Ongoing clinical trials are evaluating the efficacy and safety of RNAi therapeutics.
Related Concept Videos
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...